Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.


mare and foal in a field

Settle® Now Available in Canada

Settle® immunotherapy for equine endometritis is now available in Canada. It's also sold in the USA, Australia, New Zealand and UAE. Settle is compatible with conventional treatments and is safe with natural breeding or AI.

close up of a mare and foal

Settle® Approved for Canadian Market

NovaVive's immunotherapy for equine endometritis, Settle®, has received approval for sale in Canada from the Canadian Food Inspection Agency (CFIA). The product is expected to launch in the first quarter of this year.

foal with mare in field

Positive Data from Endometrial Cups Study with Settle® Presented at International Symposium

Data from a U.S. study using NovaVive's immunotherapy for equine endometritis, Settle®, to treat endometrial cups was presented today at the International Symposium on Equine Reproduction (ISER) in Foz do Iguaçu, Brazil.

mare and foal + product box and vial

U.S. Study Demonstrates Positive Effect of Settle® on Endometrial Cups

Data from a study conducted by Gluck Equine Research Center (UKY) and Rood & Riddle Equine Hospital has demonstrated efficacy of Settle® to treat endometrial cups in mares. No other treatment has been found effective to date.

Sign up to stay up-to-date with NovaVive news.